Yahoo Web Search

Search results

    • Image courtesy of reddit.com

      reddit.com

      • Alaska is known for its icy landscapes, sprawling wildernesses, and the aurora borealis. Due to its distance from the other states and its climate and terrain, it is officially nicknamed “The Last Frontier.” It is also known as “The Land of the Midnight Sun” because the sun never seems to set between April and August.
  1. People also ask

  2. society.asco.org › about-ascoAbout ASCO | ASCO

    ASCO’s growing roster of cutting-edge journals serves readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research and research that informs the delivery of efficient, high-quality cancer care across the globe.

  3. The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

  4. ASCO Breakthrough is your gateway to up-to-the-minute clinical research advances across multiple disease sites. Uncover how global knowledge-sharing translates to high-quality care for all people affected by cancer worldwide.

  5. society.asco.org › about-asco › overviewSociety History - ASCO

    Over five decades, ASCO and its members have established and advanced the field of modern clinical oncology. In many ways, the story of ASCO is the story of progress against cancer . As ASCO grew from its original seven members to more than 50,000 today, national funding for cancer research increased from less than $200 million to more than $5 ...

  6. ASCO’s publications—including the Society’s flagship publication, the Journal of Clinical Oncology—serve readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research that informs the delivery of high-quality patient care across the globe.

  7. Feb 2, 2021 · ASCO's Clinical Cancer Advances report highlights current trends in the field and identifies cancer research priorities that have great potential to advance progress against cancer. The report, now in its 16th edition, is developed by a 26-member editorial board of experts in a range of cancer types, subspecialties, and care issues.

  8. Jul 13, 2020 · Purpose. To update the guideline to include new anticancer agents, antiemetics, and antiemetic regimens and to provide recommendations on the use of dexamethasone as a prophylactic antiemetic in patients receiving checkpoint inhibitors (CPIs).

  1. People also search for